Come up with a name for your new list and we'll add to it:
Zymenex raised a round of funding on August 01, 2007. Investors include
British Trust for the Myelin Project.
Zymenex, formerly Heme Biotech, is a a Danish biopharmaceutical company, founded in 1998, with headquarters in Hilleroed north of Copenhagen, Denmark and research laboratories in Stockholm, Sweden. Th…